Hilgeroth A - Search Results

1

Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells.

Duarte N, Járdánházy A, Molnár J, Hilgeroth A, Ferreira MJ. Duarte N, et al. Among authors: hilgeroth a. Bioorg Med Chem. 2008 Oct 15;16(20):9323-30. doi: 10.1016/j.bmc.2008.08.071. Epub 2008 Aug 31. Bioorg Med Chem. 2008. PMID: 18824363

2

Synthesis and Evaluation of Novel Substituted N-Aryl 1,4-Dihydropyridines as Antituberculostatic Agents.

Seitz L, Reiling N, Vorreiter C, Sippl W, Kessler S, Hilgeroth A. Seitz L, et al. Among authors: hilgeroth a. Med Chem. 2024;20(1):30-39. doi: 10.2174/1573406419666230622121512. Med Chem. 2024. PMID: 37349995

3

Synthesis and first biological evaluation of 1-aza-9-oxafluorenes as novel lead structures for the development of small-sized cytostatics.

Brachwitz K, Hilgeroth A. Brachwitz K, et al. Among authors: hilgeroth a. Bioorg Med Chem Lett. 2002 Feb 11;12(3):411-3. doi: 10.1016/s0960-894x(01)00769-7. Bioorg Med Chem Lett. 2002. PMID: 11814809

4

The interaction between resistance modifiers such as pyrido[3,2-g]quinoline, aza-oxafluorene and pregnane derivatives with DNA, plasmid DNA and tRNA.

Sharples D, Spengler G, Molnár J, Antal Z, Molnár A, Kiss JT, Szabó JA, Hilgeroth A, Gallo S, Mahamoud A, Barbe J. Sharples D, et al. Among authors: hilgeroth a. Eur J Med Chem. 2005 Feb;40(2):195-202. doi: 10.1016/j.ejmech.2004.10.011. Eur J Med Chem. 2005. PMID: 15694654

5

Correlation of calculated molecular orbital energies of some phenothiazine compounds with MDR reversal properties.

Hilgeroth A, Molnár A, Molnár J, Voigt B. Hilgeroth A, et al. Eur J Med Chem. 2006 Apr;41(4):548-51. doi: 10.1016/j.ejmech.2005.11.011. Epub 2006 Mar 3. Eur J Med Chem. 2006. PMID: 16516350

6

Biological evaluation of bishydroxymethyl-substituted cage dimeric 1,4-dihydropyridines as a novel class of p-glycoprotein modulating agents in cancer cells.

Richter M, Molnár J, Hilgeroth A. Richter M, et al. Among authors: hilgeroth a. J Med Chem. 2006 May 4;49(9):2838-40. doi: 10.1021/jm058046w. J Med Chem. 2006. PMID: 16640345

7

Physicochemical characteristics of novel P-glycoprotein inhibitors of the cage dimeric 1,4-dihydropyridine type.

Wollmann J, Molnár J, Hilgeroth A. Wollmann J, et al. Among authors: hilgeroth a. Med Chem. 2006 Nov;2(6):565-8. doi: 10.2174/1573406410602060565. Med Chem. 2006. PMID: 17105437

8

Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors.

Voigt B, Coburger C, Monár J, Hilgeroth A. Voigt B, et al. Among authors: hilgeroth a. Bioorg Med Chem. 2007 Aug 1;15(15):5110-3. doi: 10.1016/j.bmc.2007.05.036. Epub 2007 May 18. Bioorg Med Chem. 2007. PMID: 17533131

9

Novel insight in structure-activity relationship and bioanalysis of P-glycoprotein targeting highly potent tetrakishydroxymethyl substituted 3,9-diazatetraasteranes.

Coburger C, Wollmann J, Baumert C, Krug M, Molnár J, Lage H, Hilgeroth A. Coburger C, et al. Among authors: hilgeroth a. J Med Chem. 2008 Sep 25;51(18):5871-4. doi: 10.1021/jm800480y. Epub 2008 Aug 21. J Med Chem. 2008. PMID: 18714979

10

Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells.

Lage H, Duarte N, Coburger C, Hilgeroth A, Ferreira MJ. Lage H, et al. Among authors: hilgeroth a. Phytomedicine. 2010 May;17(6):441-8. doi: 10.1016/j.phymed.2009.07.009. Epub 2009 Aug 13. Phytomedicine. 2010. PMID: 19682879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters